These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 6955071

  • 21. Busulphan lung in childhood.
    Oakhill A, Green ID, Knowlson GT, Cameron AH, Shah KJ, Hill FG, Mann JR.
    J Clin Pathol; 1981 May; 34(5):495-500. PubMed ID: 6941971
    [Abstract] [Full Text] [Related]

  • 22. Chronic granulocytic leukaemia. A study of 160 cases.
    Kumar L, Sagar TG, Maitreyan V, Majhi U, Shanta V.
    J Assoc Physicians India; 1990 Dec; 38(12):899-902. PubMed ID: 2096123
    [Abstract] [Full Text] [Related]

  • 23. Myeloid karyotype and the malignant phase of chronic granulocytic leukaemia.
    Lilleyman JS, Potter AM, Watmore AE, Cooke P, Sokol RJ, Wood JK.
    Br J Haematol; 1978 Jul; 39(3):317-23. PubMed ID: 279354
    [Abstract] [Full Text] [Related]

  • 24. The treatment of chronic granulocytic leukaemia.
    Spiers AS.
    Br J Haematol; 1976 Mar; 32(3):291-8. PubMed ID: 766818
    [No Abstract] [Full Text] [Related]

  • 25. Effects of high dose busulphan on leukaemic progenitor cells in chronic myeloid leukaemia.
    Morstyn G, Sullivan J, Fairhead S, Cowling D, Hurley T.
    Aust N Z J Med; 1981 Dec; 11(6):609-14. PubMed ID: 6949537
    [Abstract] [Full Text] [Related]

  • 26. Busulphan versus combination chemotherapy for initial treatment of chronic granulocytic leukaemia.
    Jacobs P.
    Am J Hematol; 1986 Aug; 22(4):375-80. PubMed ID: 3460327
    [Abstract] [Full Text] [Related]

  • 27. Comparison of busulphan, hydroxyurea and allogeneic bone marrow transplantation (BMT) in chronic myeloid leukaemia: BMT prolongs survival.
    Olsson-Strömberg U, Simonsson B, Ahlgren T, Björkholm M, Carlsson K, Gahrton G, Hast R, Löfvenberg E, Linder O, Ljungman P, Malm C, Paul C, Rödjer S, Turesson I, Udén AM, Wahlin A, Killander A, Wadman B, Westin J, Vikrot O, Zettervall O, Oberg G, Swedish CML Study Group.
    Hematol J; 2004 Aug; 5(6):462-6. PubMed ID: 15570285
    [Abstract] [Full Text] [Related]

  • 28. [Chromosome aberrations in busulphan therapy (author's transl)].
    Gebhart E, Schwanitz G, Hartwich G.
    Dtsch Med Wochenschr; 1974 Jan 11; 99(2):52-56. PubMed ID: 4520646
    [No Abstract] [Full Text] [Related]

  • 29. Papilloedema in chronic granulocytic leukaemia.
    Stainsby D, Elleray E, Anderson J, Hamilton PJ, Thompson RB.
    Br J Haematol; 1983 Oct 11; 55(2):243-9. PubMed ID: 6577908
    [Abstract] [Full Text] [Related]

  • 30. [High-dose busulfan with subsequent bone marrow transplantation in poor-risk forms of leukemia].
    Urban C, Slavc I, Kaulfersch W, Teubl I.
    Wien Klin Wochenschr; 1987 Mar 06; 99(5):144-9. PubMed ID: 3554777
    [Abstract] [Full Text] [Related]

  • 31. Longitudinal study of serum ferritin concentrations in chronic granulocytic leukaemia.
    Cervantes F, Marti JM, Piera C, Reverter JC, Rozman C.
    Acta Haematol; 1988 Mar 06; 80(1):13-6. PubMed ID: 3135687
    [Abstract] [Full Text] [Related]

  • 32. Busulphan and the lungs. Absence of lung function disturbance in patients treated with busulphan.
    Comhaire F, Van Hove W, Van Ganse W, Van der Straeten M.
    Scand J Respir Dis; 1972 Mar 06; 53(5):265-73. PubMed ID: 4508954
    [No Abstract] [Full Text] [Related]

  • 33. A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Ringdén O, Labopin M, Tura S, Arcese W, Iriondo A, Zittoun R, Sierra J, Gorin NC.
    Br J Haematol; 1996 Jun 06; 93(3):637-45. PubMed ID: 8652385
    [Abstract] [Full Text] [Related]

  • 34. Second transplants for patients with chronic myeloid leukaemia in relapse after original transplant with T-depleted donor marrow: feasibility of using busulphan alone for re-conditioning.
    Cullis JO, Schwarer AP, Hughes TP, Hows JM, Franklin I, Morgenstern G, Goldman JM.
    Br J Haematol; 1992 Jan 06; 80(1):33-9. PubMed ID: 1536808
    [Abstract] [Full Text] [Related]

  • 35. Busulphan and melphalan prior to autologous transplantation for myeloid malignancies.
    Cony-Makhoul P, Marit G, Boiron JM, Puntous M, Reiffers J.
    Bone Marrow Transplant; 1995 Jul 06; 16(1):69-70. PubMed ID: 7581131
    [Abstract] [Full Text] [Related]

  • 36. Cholestatic jaundice following treatment of chronic granulocytic leukemia with busulphan.
    Underwood JC, Shahani RT, Blackburn EK.
    J Clin Pathol; 1970 Dec 06; 23(9):827. PubMed ID: 5278972
    [No Abstract] [Full Text] [Related]

  • 37. [Lymphoid blast crisis in chronic myelogenous leukemia].
    Ranft K.
    Dtsch Med Wochenschr; 1984 Jan 06; 109(1):20-3. PubMed ID: 6581956
    [Abstract] [Full Text] [Related]

  • 38. Chronic granulocytic leukemia: long-term remission in a patient with familial sarcoidosis.
    Cheng DS, Kitahara M, Logan KH.
    South Med J; 1979 Jun 06; 72(6):645-7. PubMed ID: 287201
    [Abstract] [Full Text] [Related]

  • 39. Polycythemia vera treated with -32p and myleran: development of chronic granulocytic leukemia with chromosomal abnormalities in one patient.
    Staven P, VAN DER Hagen CB, Vogt E, Sandnes K.
    Clin Genet; 1975 Mar 06; 7(3):227-31. PubMed ID: 1056276
    [Abstract] [Full Text] [Related]

  • 40. Increase in serum alkaline phosphatase (S-ALP) in chronic myelocytic leukemia--sign of drug-induced cholestasis?
    Hast R.
    Acta Med Scand; 1978 Mar 06; 203(1-2):93-4. PubMed ID: 272822
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.